A new method allows real-time-visualisation of how the HI virus spreads between living T helper cells and which molecules it requires for this purpose.

How can biotechnology and bioeconomy contribute to establish a sustainable and circular economy? Nearly 500 attendees discussed latest trends at EFIB 2019 in Brussels. 

Rottapharm Biotech (Monza, Italy) has published detailed results from a clinical Phase II trial of CR4056 in chronic pain from knee osteoarthritis.

Spain’s biotech association Asebio announced new record numbers from its biotech investor day held as part of the European Biotech Week.

Swiss drug discovery analytics specialist Creoptix AG has raised CHF8m in a Series C financing for commercial expansion.

Entasis Therapeutics Inc (Waltham, USA) and non for profit organisation GARDP (Geneva, Switzerland) have initiated Phase III testing of the novel antibiotic zoliflodacin to treat infections with the WHO priority pathogen N. gonorrhoea.

BASF SE has strengthened its capabilities in recombinant production of natural ingredients by acquiring Dutch Isobionics BV and collaborating with Conagen Inc.

290 participants from 18 nations at the late summer edition of the European Chemistry Partnering in Düsseldorf

  • High level or participation from Southern and Eastern Europe
  • Attendance record and more than 500 arranged networking meetings
  • 4th European Chemistry Partnering will take place on 27 February 2020 in Frankfurt
  •  Podcast of the panel discussion “Digitization Networking in Chemistry” available soon

An antimicrobial molecule produced by the human microbiota gut may help fight drug-resistant infections.

German Tacalyx GmbH has baged €7m in seed financing to generate antibodies that home in on tumour-antigene specific carbohydrates (TACAs) of glycans.